GlycoMimetics Inc reports results for the quarter ended in September - Earnings Summary

Crescent Biopharma

03/11/2021 11:34

* GlycoMimetics Inc  GLYC.OQ  reported a quarterly adjusted loss
of 34 cents​​ per share for the quarter ended in September. The
mean expectation of four analysts for the quarter was for a loss
of 32 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* GlycoMimetics Inc's reported EPS for the quarter was a loss
of 34 cents​.
* The mean earnings estimate of analysts had risen by about 1.6%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* GlycoMimetics Inc shares had fallen by 6.4% this quarter and
lost 45.5% so far this year.
* The company reported a quarterly loss of $17.33 million.
* Wall Street's median 12-month price target for GlycoMimetics
Inc is $14.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 3 at 11:34 a.m.
 ​All figures in US dollars unless otherwise stated